Analgesic abuse.
Murray RM.
Lancet. 1971 Dec 4;2(7736):1260-1. doi: 10.1016/s0140-6736(71)90576-9.
Analgesic abuse in the elderly. Renal sequelae and management.
Elseviers MM, De Broe ME.
Drugs Aging. 1998 May;12(5):391-400. doi: 10.2165/00002512-199812050-00005.
Analgesic nephropathy: is it caused by multi-analgesic abuse or single substance use?
Elseviers MM, De Broe ME.
Drug Saf. 1999 Jan;20(1):15-24. doi: 10.2165/00002018-199920010-00003.
Ketamine for chronic pain: risks and benefits.
Niesters M, Martini C, Dahan A.
Br J Clin Pharmacol. 2014 Feb;77(2):357-67. doi: 10.1111/bcp.12094.
How addictive are gabapentin and pregabalin? A systematic review.
Bonnet U, Scherbaum N.
Eur Neuropsychopharmacol. 2017 Dec;27(12):1185-1215. doi: 10.1016/j.euroneuro.2017.08.430. Epub 2017 Oct 5.
Analgesic-abuse nephropathy.
Blewitt GA.
JAMA. 1982 Sep 3;248(9):1063-4.
Analgesic abuse.
Madden JS.
Nurs Times. 1974 May 23;70(21):795-6.
Use and abuse of over-the-counter analgesic agents.
Abbott FV, Fraser MI.
J Psychiatry Neurosci. 1998 Jan;23(1):13-34.
[Analgesic abuse and psychiatric comorbidity in headache patients].
Radat F, Irachabal S, Swendsen J, Henry P.
Encephale. 2002 Sep-Oct;28(5 Pt 1):466-71.
NKTR-181: A Novel Mu-Opioid Analgesic with Inherently Low Abuse Potential.
Miyazaki T, Choi IY, Rubas W, Anand NK, Ali C, Evans J, Gursahani H, Hennessy M, Kim G, McWeeney D, Pfeiffer J, Quach P, Gauvin D, Riley TA, Riggs JA, Gogas K, Zalevsky J, Doberstein SK.
J Pharmacol Exp Ther. 2017 Oct;363(1):104-113. doi: 10.1124/jpet.117.243030. Epub 2017 Aug 4.
